Search Results - "Bond, Wesley S."
-
1
Evidence That Erythropoietin Modulates Neuroinflammation through Differential Action on Neurons, Astrocytes, and Microglia
Published in Frontiers in immunology (22-10-2014)“…Neuroinflammation is a normal and healthy response to neuronal damage. However, excessive or chronic neuroinflammation exacerbates neurodegeneration after…”
Get full text
Journal Article -
2
Inhibitors of metalloprotease, γ-sectretase, protein kinase C and Rho kinase inhibit wild-type adenoviral replication
Published in PloS one (2020)“…Adenoviruses cause upper respiratory infections, conjunctivitis, keratitis, and gastrointestinal illness. These can be fatal in immunocompromised individuals…”
Get full text
Journal Article -
3
Erythropoietin Slows Photoreceptor Cell Death in a Mouse Model of Autosomal Dominant Retinitis Pigmentosa
Published in PloS one (01-06-2016)“…To test the efficacy of systemic gene delivery of a mutant form of erythropoietin (EPO-R76E) that has attenuated erythropoietic activity, in a mouse model of…”
Get full text
Journal Article -
4
Tumorspheres but not adherent cells derived from retinoblastoma tumors are of malignant origin
Published in PloS one (24-06-2013)“…Verification that cell lines used for cancer research are derived from malignant cells in primary tumors is imperative to avoid invalidation of study results…”
Get full text
Journal Article -
5
Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma
Published in Molecular therapy (01-02-2016)“…Glaucoma, a common cause of blindness, is currently treated by intraocular pressure (IOP)–lowering interventions. However, this approach is insufficient to…”
Get full text
Journal Article -
6
Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress
Published in Journal of neuroinflammation (15-02-2016)“…Glaucoma is a complex neurodegeneration and a leading cause of blindness worldwide. Current therapeutic strategies, which are all directed towards lowering the…”
Get full text
Journal Article -
7
Versican G1 domain enhances adenoviral-mediated transgene expression and can be modulated by inhibitors of the Janus kinase (JAK)/STAT and Src family kinase pathways
Published in The Journal of biological chemistry (01-09-2017)“…To examine the biochemical influences that may contribute to the success of gene therapy for ocular disorders, the role of versican, a vitreous component, in…”
Get full text
Journal Article -
8
Embryonic retinal tumors in SV40 T-Ag transgenic mice contain CD133+ tumor-initiating cells
Published in Investigative ophthalmology & visual science (08-06-2012)“…Human retinoblastomas form during the proliferative phase of retina development and are caused by mutations that result in absent or functionally defective Rb…”
Get full text
Journal Article -
9
The Liberation of CD44 Intracellular Domain Modulates Adenoviral Vector Transgene Expression
Published in The Journal of biological chemistry (21-09-2012)“…The success of gene therapy in the ocular environment is partly due to the presence of hyaluronan in vitreous. Here we explore the mechanism of…”
Get full text
Journal Article -
10
Establishment and propagation of human retinoblastoma tumors in immune deficient mice
Published in Journal of visualized experiments (04-08-2011)“…Culturing retinoblastoma tumor cells in defined stem cell media gives rise to primary tumorspheres that can be grown and maintained for only a limited time…”
Get full text
Journal Article -
11
Inhibitors of metalloprotease, [gamma]-sectretase, protein kinase C and Rho kinase inhibit wild-type adenoviral replication
Published in PloS one (22-07-2020)“…Adenoviruses cause upper respiratory infections, conjunctivitis, keratitis, and gastrointestinal illness. These can be fatal in immunocompromised individuals…”
Get full text
Journal Article -
12
108. Versican G1 Domain Stimulates Adenoviral Transgene Expression in a JAK/STAT Dependent Manner
Published in Molecular therapy (01-05-2015)Get full text
Journal Article -
13
204. Treatment with Modified Erythropoietin Gene Therapy Is Neuroprotective in a Mouse Model of Induced Ocular Hypertension
Published in Molecular therapy (01-05-2015)Get full text
Journal Article -
14
Safety and angiogenic effects of systemic gene delivery of a modified erythropoietin
Published in Gene therapy (01-05-2015)“…Erythropoietin (EPO) is critical for red blood cell production and is also an effective neuroprotective agent. However, it may contribute to pathological…”
Get full text
Journal Article -
15
Evaluation of porcine aortic valve interstitial cell activity using different serum types in two- and three-dimensional culture
Published in Tissue engineering (01-02-2007)“…Unlike established cell lines used in the biotechnology industry, primary cells used in tissue engineering require culture media to be supplemented with serum…”
Get more information
Journal Article -
16
Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
Published in Journal of visualized experiments (04-08-2011)Get full text
Journal Article